ALGS vs L · rev $3.6M vs P/E 14, rev $18.45B
Aligos Therapeutics Inc (ALGS) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
ALGS currently screens at market cap $44.1M. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the ALGS and L stock pages for the full models.
Not investment advice.